Simvastatin, Xenical, Nasacort Switch Decisions Imminent In New Zealand
This article was originally published in The Tan Sheet
Executive Summary
New Zealand's Ministry of Health is expected to issue a decision on behind-the-counter switches for simvastatin, Roche's Xenical and Aventis' Nasacort within four to six weeks